Categories Earnings, Retail

Earnings: Tyson Foods Q2 profit, sales beat Street view

Packaged food company Tyson Foods (NYSE: TSN) Monday reported better-than-expected earnings and revenues for the second quarter of 2019.

The Springdale, Arkansas-based meat manufacturer posted adjusted earnings of $1.20 per share for the quarter, compared to $1.27 per share in the second quarter of 2018. Analysts had forecast a lower number. Reports profit rose to $430 million or $1.17 per share in the second quarter from $316 million or $0.85 per share a year earlier.Tyson Foods Q2 2019 earnings infographic

Driving the bottom-line growth, net sales climbed 6.9% annually to $10.44 billion during the three-month period, surpassing the market forecast.

Sales volume of beet increased due to improved availability of cattle supply and stronger demand for beef products. There was also an increase in the average sales price.

Driving the bottom-line growth, net sales climbed 6.9% annually to $10.44 billion during the three-month period

Sales volume of pork moved up amid increased domestic availability of live hogs. However, average sales price decreases in the segment. Aided by incremental volume from business acquisitions, the sales volume of chicken rose, while average sales price decreased. Meanwhile, Prepared Foods registered a decline in sales volume mainly due to business divestitures. But, the average sales price increased owing to a favorable product mix.

“The Prepared Foods segment produced its second consecutive quarter of record return on sales. Both the Beef and Pork segments were solid performers, while the Chicken segment is poised for improvement following what we believe are its margin lows for the year,” said CEO Noel White.

The management also reaffirmed its full-year 2019 guidance for adjusted earnings in the range of $5.75 per share to $6.10 per share.

Tyson Foods shares gained 41% since the beginning of 2019 and 10% over the past twelve months. The stock closed the last trading session slightly lower.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top